financetom
Business
financetom
/
Business
/
Lululemon Athletica May See Sales-Driven Q4 EPS Upside, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lululemon Athletica May See Sales-Driven Q4 EPS Upside, Morgan Stanley Says
Mar 19, 2025 9:40 AM

12:05 PM EDT, 03/19/2025 (MT Newswires) -- Lululemon Athletica ( LULU ) may report Q4 earnings per share above expectations, supported by stronger sales, though Morgan Stanley anticipates management will take a cautious approach to full-year guidance.

The company raised its Q4 guidance in January, forecasting earnings per share of $5.81 to $5.85, up from a prior range of $5.56 to $5.64, and revenue of $3.56 billion to $3.58 billion, above its previous forecast of $3.48 billion to $3.51 billion.

Morgan Stanley said in a note Wednesday that investor sentiment around Lululemon has weakened in recent weeks, with confidence in a first-half Americas revenue inflection fading. The firm believes this has lowered the bar heading into the Q4 report.

For Q1, Morgan Stanley expects sales guidance to come in slightly below Street estimates but sees earnings per share as more resilient, supported by potential cost controls and share repurchases.

Full-year sales guidance is expected to be largely in line with expectations, while earnings per share could be guided slightly below consensus, leaving room for potential outperformance, according to the note.

Lululemon is scheduled to report Q4 results on March 27.

Morgan Stanley maintained an overweight rating on the stock but lowered its price target to $411 from $420.

Price: 327.06, Change: +3.99, Percent Change: +1.23

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amneal Pharmaceuticals Says Study Evaluating Biosimilar to Xolair For Chronic Hives Achieves Endpoints
Amneal Pharmaceuticals Says Study Evaluating Biosimilar to Xolair For Chronic Hives Achieves Endpoints
Jun 25, 2025
08:46 AM EDT, 06/25/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) said Wednesday its clinical trial evaluating a proposed biosimilar to Xolair for patients with chronic idiopathic urticaria, a skin disease, achieved its primary and secondary endpoints. The confirmatory clinical efficacy and safety trial evaluating ADL-018 achieved the endpoints by establishing equivalence of therapeutic endpoints and comparable safety between...
Viking Therapeutics Begins Phase 3 Trial of Dual Agonist VK2735 in Obesity
Viking Therapeutics Begins Phase 3 Trial of Dual Agonist VK2735 in Obesity
Jun 25, 2025
08:46 AM EDT, 06/25/2025 (MT Newswires) -- Viking Therapeutics ( VKTX ) said Wednesday it has started a phase 3 trial of VK2735, its dual agonist of glucagon-like peptide 1, or GLP-1, and glucose-dependent insulinotropic polypeptide, or GIP, receptors to potentially treat obesity. The trial includes two studies evaluating a subcutaneous formulation of VK2735 over 78 weeks, the company said,...
Cereal Giant General Mills' Cautious Outlook Offers Little Crunch, Stock Falls
Cereal Giant General Mills' Cautious Outlook Offers Little Crunch, Stock Falls
Jun 25, 2025
Cereal Giant General Mills, Inc. ( GIS ) shares dipped in premarket trading Wednesday after the company posted mixed fourth-quarter results and issued a cautious full-year outlook. The global packaged food company registered quarterly adjusted earnings per share of 74 cents, beating the analyst consensus estimate of 71 cents. Quarterly sales of $4.56 billion (down 3% year over year) missed...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved